Findings that shed new light on the possible pathogenesis of a disease or an adverse effect
Fatal pulmonary Mycobacterium xenopi in a patient with rheumatoid arthritis receiving etanercept
1 Soroka University Medical Center, Beer-Sheva, Beer-Sheva, Beer-Sheva, Israel
2 University of Toronto, Toronto, Toronto, Ontario, M5T 2S8, Canada
3 Toronto Western Hospital, Respiratory Medicine, 452, 7 East, 399 Bathurst Street, Toronto, Ontario, M5T 2S8, Canada
Correspondence to:
ted.marras{at}utoronto.ca
In this case study, a 71 year old man with emphysema and severe rheumatoid arthritis, previously treated with a TNF
receptor antagonist, presented with progressive dyspnoea and weight loss. Thoracic imaging revealed extensive destruction of the left lung and this was associated with positive Mycobacterium xenopi cultures from respiratory samples. Anti-mycobacterial chemoptherapy was poorly tolerated and the patient subsequently died from respiratory failure and generalised wasting.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
- Full Text
- Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
Services
- Email this link to a friend
- Similar articles in this journal
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with
Register for free content
The full text of all Editor's Choice articles and summaries of every article are free without registration
The full text of Images in ... articles are free to registered users
Only fellows can access the full text of case reports (apart from Editor's Choice) - become a fellow today, or encourage your institution to, so that together we can grow and develop this resource
Don't forget to sign up for content alerts so you keep up to date with all the case reports as they are published, and let us know what you think by commenting on the Editor's blog
